Back to results
US 10,137,245 B2Granted
Central site photoplethysmography, medication administration, and safety
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsRichard J. Melker, Donn M. Dennis, Jeremy Melker, Mark Rice, Robert Hurley, Mark Gold, Richard Allen
Life of this patent
Estimating the term…
Abstract
A monitoring and control system, apparatus and method for safe administration, reduction or cessation of administration of at least on medication, fluid or both, which includes at least one Central Source Site (CSS) Photoplethysmography (PPG) sensor coupled to means for control of delivery of the at least one medication, fluid or both.
Claims11
A system for monitoring and control for safe administration, reduction or cessation of administration of at least one of medication to a subject, comprising:
- (a) at least one photoplethysmography (PPG) sensor adapted to secure to a central source site of the subject;
- (b) an infusion pump for delivering the at least one medication to the subject, wherein the infusion pump comprises an infusion controller for increasing or decreasing flow of medication to the subject;
- and
- (c) an infusion pump agnostic safety device that is adapted to be deployed onto tubing adapted to deliver the at least one medication from the infusion pump to the subject, wherein the safety device comprises an occlusion apparatus and an occlusion controller, wherein the occlusion controller receives signals from the PPG sensor, calculates at least one respiratory parameter based on the signals from the PPG sensor, and if the at least one respiratory parameter is determined by the occlusion controller to be adverse, the occlusion controller directs the occlusion apparatus to partially or completely occlude the tubing
- wherein the infusion pump agnostic safety device only occludes the tubing in the event the occlusion controller determines that an adverse event has occurred.
2 more elements
Dependencies are inferred from the claim text.